Osteoporosis is typically considered to be

Size: px
Start display at page:

Download "Osteoporosis is typically considered to be"

Transcription

1 THE IMPACT OF LONG-TERM ANTIEPILEPTIC DRUG USE ON BONE HEALTH * Alison M. Pack, MD ABSTRACT A growing amount of scientific literature describing long-term follow-up in patients taking antiepileptic drugs (AEDs) indicates a probable relationship between osteoporosis and the longterm use of these drugs. However, the exact influence on fracture risk is not yet clear. Osteoporosis in patients with epilepsy is a serious problem. Detriments in bone health can be measured as radiographic, pathologic, and biochemical abnormalities. Most of the data showing bone disease and increased fractures with AED use are in patients taking the older drugs. Several new AEDs have become available in the past decade, but the data for them in this regard is limited. Multiple treatments are available for bone disease, including calcium and vitamin D supplementation, bisphosphonates, hormone replacement, calcitonin, and parathyroid hormone. The efficacy and safety of these treatments in the general population are established but there are few studies of these treatments involving patients taking AEDs. Clinicians might consider a monitoring schedule for patients taking phenytoin and phenobarbital, particularly if these patients have other risk factors that contribute to bone disease. Clinicians should discuss a regimen of recommended daily allowances of calcium and vitamin D with all patients taking AEDs, regardless of the patient s age or sex. (Adv Stud Med. 2005;5(6C):S567-S571) *Based on a presentation given by Dr Pack at the 2004 Annual Meeting of the American Epilepsy Society. Assistant Professor of Clinical Neurology, Columbia University, New York, New York. Address correspondence to: Alison M. Pack, MD, Assistant Professor of Clinical Neurology, Columbia University, 710 West 168th Street, New York, NY Osteoporosis is typically considered to be a disease of postmenopausal women and is not often considered by neurologists during routine patient management. However, a growing amount of scientific literature describing long-term follow-up in patients taking antiepileptic drugs (AEDs) indicates a probable relationship between osteoporosis and the long-term use of these drugs. Although the exact influence on fracture risk is not yet clear, epilepsy and AEDs have been associated with an increased risk of fractures. 1-5 Osteoporosis in patients with epilepsy is a serious problem: patients with epilepsy already are at an increased risk of fractures because of falls during seizures; epilepsy can be a lifelong disorder requiring lifelong treatment; women constitute a significant portion of patients with epilepsy and are at an increased risk of osteoporosis simply because of their hormonal changes; there is a paucity of studies examining bone health with many of the newer AEDs, thus those patients risks are not yet known; and a recent study indicates that a minority of neurologists (40% of pediatric neurologists and 28% of neurologists treating adult patients) screen for bone disease in their patients taking AEDs. 6 MANIFESTATION OF BONE DISEASE Bone health is a dynamic process, a coupling of bone resorption by osteoclasts and bone formation by osteoblasts. Poor bone health can manifest as osteopenia, osteoporosis, osteomalacia, and fractures. Osteopenia is a precursor to osteoporosis and is marked by decreased calcification, decreased bone density, or reduced bone mass. These conditions result from accelerated bone resorption so that the rate of bone formation lags behind and bone mass overall decreases. The standard for assessing bone density is through dual x-ray absorptiometry. Several studies have S567

2 documented decreased bone mass in several body sites in patients taking AEDs, in cohorts ranging in age from children to the elderly At Columbia University, we performed a retrospective study to measure bone mineral density in an adult outpatient population (n = 153) who were receiving AEDs (specifically, those drugs that induce hepatic cytochrome P450 enzymes). Study results showed significantly increased osteoporosis and osteopenia in younger men and women (<50 years). In fact, the rate of osteoporosis was 10 times greater in the study group than the expected rate for the general population (Figure). 14 Osteomalacia describes softening of the bone as a result of increased osteoid or unmineralized bone, thus it increases risk of fracture. Osteomalacia was originally described in the 1960s and 70s in institutionalized patients, but it has not been frequently reported since then. The apparent decrease in prevalence is most likely explained by the inadequate diet, poor sunlight exposure, and limited exercise of institutionalized patients versus community-dwelling patients with epilepsy. Fractures are the most important manifestation of bone-mineral density decline. Patients with epilepsy are at an increased risk of injury and fractures as a result of their seizures; however, fractures have been described at multiple sites (ie, hip, radius, ankle, and vertebrae) in patients taking AEDs. 3,15-19 Results in some studies did not suggest a relationship between AED use and increased fracture risk; however, some studies found that the increase in fractures was independent of seizure frequency, suggesting that AED use increases the risk of fracture. 2,3,16,18 Biochemical abnormalities, in addition to radiographic and pathologic abnormalities, have been described in patients taking AEDs. As summarized in Table 1, calcium, phosphate, and vitamin D metabolites are decreased in patients taking AEDs. However, markers of bone formation and resorption, in addition to parathyroid hormone (which is involved in homeostasis of calcium levels), are increased compared to normal levels ANTIEPILEPTIC DRUGS ASSOCIATED WITH BONE DISEASE Most of the data showing bone disease and increased fractures with AED use are in patients taking the older drugs. However, several new AEDs have become available in the past decade, but data in this regard are limited. Phenytoin, phenobarbital, and primidone are the most commonly reported agents associated with adverse effects on bone health. These agents are all potent inducers of the hepatic cytochrome P450 enzyme system. Studies of patients taking these medications reveal decreased bone density; reduced serum calcium, phosphate, and vitamin D levels; and increased bone turnover. 3,13,20 Carbamazepine is also an inducer of the cytochrome P450 enzyme system; however, the data regarding indices of bone and mineral metabolism and bone turnover and bone mineral density are conflicting. Some studies find no changes in measures of bone health, whereas other studies find significant changes in patients taking this drug. 10,20,22-28 One study using Figure. Comparison of Bone Mineral Density Between Antiepileptic Drug Users and the General Population Patients, % Normal density Osteopenia Expected Women and men with epilepsy Osteoporosis Percentages of normal density, osteopenia, and osteoporosis at the femoral neck of the hip in 50-yearold men and women receiving antiepileptic drugs compared to expected percentages from a healthy population of white postmenopausal women. Reprinted with permission from Pack et al. Epilepsy Behav. 2003;4: S568 Vol. 5 (6C) June 2005

3 ultrasonography revealed decreased cortical bone mass with carbamazepine use, whereas a recent study showed limited increase in fracture risk. 2,25 Of note, the study showing limited increase in fracture risk is the only study to examine individual AEDs; the other studies tended to analyze AED use as a group. Another study evaluated markers of bone turnover before treatment with carbamazepine in adolescent girls and boys and repeated these measurements after 1 and then 2 years of initiating treatment. The findings were compared to a control population matched by age, sex, and pubertal status. 22,23 The results showed significantly elevated markers of bone turnover in the group treated with carbamazepine compared to the control group. 2 These results are important for their insights into the bone effects of a single AED and a comparison to bone health before treatment initiation and because bone density increases during the first 20 to 30 years of life to obtain peak bone mineral density. The increased turnover during these years suggests that the peak bone mineral density will be affected by treatment with carbamazepine. Adolescents taking AEDs may not be able to build the same bone mineral density as other healthy children and young adults. A leading theory to explain the effects of enzyme-inducing AEDs on bone health is that hepatic induction of the cytochrome P450 enzyme system leads to increased catabolism of vitamin D, secondary hyperparathyroidism, and increased bone turnover. 29 Valproate, by contrast, inhibits the cytochrome P450 enzymes. Interestingly, a study comparing valproate with carbamazepine use in children showed bone loss with valproate only. 8 Another study involving adults also found decreased bone mineral density and elevated markers of bone turnover when compared to a control group without epilepsy who were not taking AEDs. 21 There are few studies assessing bone health with the newer AEDs (eg, lamotrigine, topiramate, and zonisamide). One study of a pediatric population found bone loss with lamotrigine use, but the authors suggest that the short stature, low bone mineral density, and reduced bone formation may have been caused by limited activity rather than the AEDs because the measures of bone density correlated with activity level. 9 At Columbia University, we studied bone mineral density and indices of bone and mineral metabolism, including markers of bone turnover, in normally cycling premenopausal women taking phenytoin, carbamazepine, valproate, and lamotrigine. Those women taking lamotrigine had significantly higher calcium levels when compared to the other women. Bone-specific alkaline phosphatase (a marker of bone resorption) was significantly elevated in women taking phenytoin compared to lamotrigine, suggesting that lamotrigine has less effect on bone than phenytoin. 30 To date, there are no published data regarding the effects of carbonic anhydrase inhibitors (topiramate and zonisamide) on bone health. One study showed a bone-sparing effect of acetazolamide in patients with glaucoma. 31 RISK FACTORS Several other risk factors for osteoporosis are well defined: age, small body frame, white or Asian ethnicity, family history of osteoporosis, alcohol use, and smoking history. Therefore, patients who are taking AEDs even the newer agents who also have these risk factors should be considered for prophylactic treatment for osteoporosis and monitoring of bone mineral density. TREATMENT As described earlier in this article, results from a survey of neurologists practice patterns regarding bone and mineral effects of AEDs indicated that most neurologists do not screen for bone disease. Of those neurologists who screen and find evidence, approximately 40% administer calcium and vitamin D as treatment and approximately 55% refer these patients to a specialist (Table 2). Although only approximately Table 1. Biochemical Abnormalities of Bone Metabolism Associated with Antiepileptic Drug Use Calcium Phosphate Parathyroid hormone Vitamin D metabolite levels Markers of bone formation Markers of bone resporption Data from Valimaki et al 20 ; Sato et al 21 ; Verrotti et al. 22,23 Serum Serum Serum/urine S569

4 5% of the neurologists neither treat nor refer, fewer than 10% of neurologists talk to their patients about prophylactic calcium and vitamin D during AED use. These results suggest that most neurologists are not aware of the effects of AEDs on bone health, and the appropriate treatment options are not routinely used when there is evidence of bone disease. 6 Multiple treatments are available for bone disease, including calcium and vitamin D supplementation, bisphosphonates, hormone replacement, calcitonin, and parathyroid hormone. The efficacy and safety of these treatments in the general population are established, but there are few studies of these treatments in patients taking AEDs. For example, the only studies of vitamin D use in patients taking AEDs used broad ranges of high doses. Bone mineral density increased with vitamin D supplementation, but a safe recommended dose based on this study is unclear. 25 Clinicians should counsel all patients taking AEDs about taking the recommended daily allowance of calcium and vitamin D. The recommended daily allowance of calcium ranges between 1000 to 1500 mg/day, depending on age, sex, and reproductive status (Table 3). 32,33 Daily vitamin D intake for prophylaxis of bone mineral depletion is 400 to 2000 IU/day, and the endocrinology community recommends higher doses for the treatment of osteopenia and osteoporosis ( IU/day), and even higher doses for the treatment of osteomalacia ( IU/day). 34 Table 2. Practice Patterns of Neurologists Regarding Detection,Treatment, and Prevention of Bone Disease in Patients Taking Antiepileptic Drugs Table 3. Optimal Calcium Requirements Neurologists, n (%) Pediatric Adult (n = 404) (n = 624) Screen for bone disease 160 (41) 174 (28) Of neurologists who screen and find evidence of bone disease Treat with calcium or vitamin D 62 (40) 61 (37) Refer to a specialist 83 (54) 94 (57) Neither treat nor refer 8 (5) 11 (7) Prescribe prophylactic calcium or vitamin D 35 (9) 46 (7) Reprinted with permission from Valmadrid et al. Arch Neurol. 2001;58: CONCLUSIONS Antiepileptic drugs appear to negatively influence bone health, especially in patients with risk factors that also may contribute to the disease. The exact relationship between AED use and bone mineral density is not yet described completely. The most compelling evidence of a deleterious effect on bone health is with the use of phenytoin and phenobarbital. Patients taking those 2 drugs should have their bone mineral density monitored regularly. For patients taking carbamazepine and valproate, in addition to the newer medications, the recommendations are less clear. Clinicians should also consider a monitoring schedule for patients taking these drugs, particularly if they have other risk factors that contribute to bone disease. Physicians should discuss the recommended daily allowances of calcium and vitamin D with all patients taking AEDs, regardless of their age or sex. This conversation is a simple initiative that can create a long-term beneficial health outcome for patients. Group Optimal Daily Intake, mg Infants Birth to 6 months months to 1 year 600 Children 1 5 years years Adolescents/young adults years Men yrs 1000 Older than 65 years 1500 Women years 1000 Older than 50 years (postmenopausal) 1000 Taking estrogens 1500 Not taking estrogens 1500 Older than 65 years Pregnant and nursing Reprinted with permission from Pack and Morrell. Epilepsy Behav. 2004;5:S S570 Vol. 5 (6C) June 2005

5 REFERENCES 1. Lidgren L, Walloe A. Incidence of fracture in epileptics. Acta Orthop Scand. 1977;48: Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004; 45: Vestergaard P, Tigaran S, Rejnmark L, et al. Fracture risk is increased in epilepsy. Acta Neurol Scand. 1999;99: Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia. 1995;36: Espallargues M, Sampietro-Colom L, Estrada MD, et al. Identifying bone mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int. 2001;12: Valmadrid C, Voorhees C, Litt B, Schneyer CR. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol. 2001;58: Chung S, Ahn C. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev. 1994;16: Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr. 1995;127: Guo CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 2001;42: Farhat G, Yamout B, Mikati MA, et al. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002;58: Andress DL, Ozuna J, Tirschwell D, et al. Antiepileptic druginduced bone loss in young male patients who have seizures. Arch Neurol. 2002;59: Tsukahara H, Kimura K, Todoroki Y, et al. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int. 2002;44: Ensrud KE, Walczak TS, Blackwell T, et al. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology. 2004;62: Pack AM, Olarte LS, Morrell MJ, et al. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav. 2003;4: Nilsson OS, Lindholm TS, Elmstedt E, et al. Fracture incidence and bone disease in epileptics receiving long-term anticonvulsant drug treatment. Arch Orthop Trauma Surg. 1986;105: Annegers JF, Melton LJ 3rd, Sun CA, Hauser WA. Risk of age-related fractures in patients with unprovoked seizures. Epilepsia. 1989;30: Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332: Desai KB, Ribbans WJ, Taylor GJ. Incidence of five common fracture types in an institutional epileptic population. Injury. 1996;27: Persson HB, Alberts KA, Farahmand BY, Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia. 2002;43: Valimaki MJ, Tiihonen M, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res. 1994;9: Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001;57: Verrotti A, Greco R, Morgese G, Chiarelli F. Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol. 2000;47: Verrotti A, Greco R, Latini G, et al. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia. 2002;43: Hoikka V, Alhava EM, Karjalainen P, et al. Carbamazepine and bone mineral metabolism. Acta Neurol Scand. 1984;70: Pedrera JD, Canal ML, Carvajal J, et al. Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy. Eur J Clin Invest. 2000;30: Tjellesen L, Christiansen C. Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants. Acta Neurol Scand. 1982;66: Tjellesen L, Nilas L, Christiansen C. Does carbamazepine cause disturbances in calcium metabolism in epileptic patients? Acta Neurol Scand. 1983;68: Tjellesen L, Gotfredsen A, Christiansen C. Effect of vitamin D2 and D3 on bone-mineral content in carbamazepinetreated epileptic patients. Acta Neurol Scand. 1983;68: Pack AM. Antiepileptic drugs and bone disease. Clin Rev Bone Miner Metab. 2004;2: Pack AM, Morrell MJ, Marcus R, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol. 2005;57: Pierce WM Jr, Nardin GF, Fuqua MF, et al. Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res. 1991;6: Optimal calcium intake. NIH Consensus Development Conference Statement. June 6-8, National Institutes of Health Web site. Available at: gov/cons/097/097_statement.htm#cdc97t1. Accessed April 11, Pack AM, Morrell MJ. Epilepsy and bone health in adults. Epilepsy Behav. 2004;5(suppl 2):S24-S Drezner MK. Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav. 2004;5(suppl 2):S41-S47. S571

Levetiracetam Treatment Does Not Result in Broken Bones

Levetiracetam Treatment Does Not Result in Broken Bones Current Literature In Clinical Science Levetiracetam Treatment Does Not Result in Broken Bones Effects of Levetiracetam as a Monotherapy on Bone Mineral Density and Biochemical Markers of Bone Metabolism

More information

BULLETIN. Slovak Republic Ministry of Health

BULLETIN. Slovak Republic Ministry of Health BULLETIN Slovak Republic Ministry of Health Part 51-53 November 13, 2009 No. 57 CONTENTS: 52. Slovak Republic Ministry of Health Guidelines for the Diagnosis of Glucocorticoidinduced Osteoporosis 52. Slovak

More information

Clinical Policy Guideline

Clinical Policy Guideline Clinical Policy Guideline Policy Title: Bone Density Testing Policy No: B0215A.00 Effective Date: 01/01/15 Date Reviewed: 03/25/15 I. DEFINITION/BACKGROUND Bone density testing is used to estimate the

More information

Anti-epileptic drugs and osteoporosis

Anti-epileptic drugs and osteoporosis Anti-epileptic drugs and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily

More information

Osteoporosis/Bone Health in Adults as a National Public Health Priority

Osteoporosis/Bone Health in Adults as a National Public Health Priority Position Statement Osteoporosis/Bone Health in Adults as a National Public Health Priority This Position Statement was developed as an educational tool based on the opinion of the authors. It is not a

More information

Boning Up On Osteoporosis

Boning Up On Osteoporosis Boning Up On Osteoporosis Nicholas J. Avallone,, M.D. Orthopedic Surgeon Sports Medicine Specialist Conflicts of Interest I have no relationships with any company listed in this talk. Resources National

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2016 2/2017 2/2016 Description of Procedure or Service Vitamin D,

More information

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Bariatric Surgery And Skeletal Health CE APPLICATION FORM

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Bariatric Surgery And Skeletal Health CE APPLICATION FORM NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Bariatric Surgery And Skeletal Health CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal Code: Country: Phone

More information

Forteo (teriparatide) Prior Authorization Criteria

Forteo (teriparatide) Prior Authorization Criteria Forteo (teriparatide) Prior Authorization Criteria FDA APPROVED INDICATIONS AND DOSAGE 1 FDA Indication 1 : Forteo is indicated for: the treatment of postmenopausal women with osteoporosis who are at high

More information

Bone health in epilepsy

Bone health in epilepsy Chapter 40 Bone health in epilepsy HANNAH R. COCK Epilepsy Group, Atkinson Morley Regional Neuroscience Centre, St Georges University Hospitals NHS Foundation Trust, and Institute of Medical and Biomedical

More information

Osteoporosis has been identified by the US Surgeon General

Osteoporosis has been identified by the US Surgeon General New Guidelines for the Prevention and Treatment of Osteoporosis E. Michael Lewiecki, MD, and Nelson B. Watts, MD Abstract: The World Health Organization Fracture Risk Assessment Tool (FRAX ) and the National

More information

Clinical Practice Guideline for Osteoporosis Screening and Treatment

Clinical Practice Guideline for Osteoporosis Screening and Treatment Clinical Practice Guideline for Osteoporosis Screening and Treatment Osteoporosis is a condition of decreased bone mass, leading to bone fragility and an increased susceptibility to fractures. While osteoporosis

More information

Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now

Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now Laura L. Tosi, MD Director, Bone Health Program Children s National Medical Center Washington, DC Epidemiology 87-93% of children born

More information

Healthy Aging Lab: Current Research Abstracts

Healthy Aging Lab: Current Research Abstracts Healthy Aging Lab: Current Research Abstracts Arsenic Exposure and Women s Health Environmental exposure to inorganic arsenic is an indisputable source of increased risk of several human cancers and chronic

More information

Fast Facts on Osteoporosis

Fast Facts on Osteoporosis Fast Facts on Osteoporosis Definition Prevalence Osteoporosis, or porous bone, is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an

More information

Cystic fibrosis and bone health

Cystic fibrosis and bone health Cystic fibrosis and bone health Factsheet March 2013 Cystic fibrosis and bone health Introduction As we get older our bones become thinner and weaker, and may become more susceptible to fracture. However

More information

Frontier AIDS Education and Training Center

Frontier AIDS Education and Training Center Frontier AIDS Education and Training Center Vitamin D and HIV Subbulaxmi Trikudanathan, MD, MRCP, MMSc Division of Endocrinology, Metabolism and Nutrition University of Washington Medical Center Presentation

More information

Osteoporosis Assessment Using DXA and Instant Vertebral Assessment. Working Together For A Healthier Community

Osteoporosis Assessment Using DXA and Instant Vertebral Assessment. Working Together For A Healthier Community Osteoporosis Assessment Using DXA and Instant Vertebral Assessment Working Together For A Healthier Community Osteoporosis The Silent Thief The Facts About Osteoporosis 1 in 2 women will develop osteoporosis

More information

North Carolina Rheumatology Association Position Statements

North Carolina Rheumatology Association Position Statements North Carolina Rheumatology Association Position Statements I. Biologic Agents A. Appropriate delivery, handling, storage and administration of biologic agents B. Indications for biologic agents II. III.

More information

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

Osteoporosis. What are the indications for bone mass measurement issued by National Osteoporosis Foundation?

Osteoporosis. What are the indications for bone mass measurement issued by National Osteoporosis Foundation? Osteoporosis Dr. Pradeep Kumar Shenoy C Consultant Rheumatologist, KMC Hospital, Mangalore What are the major components of the bone? The main structural elements of bone are osteoid, which is a protein

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE This is an updated guideline It incorporates the latest NICE guidance There are strong recommendations for calcium + vitamin D

More information

DEFINITION OF OSTEOPOROSIS

DEFINITION OF OSTEOPOROSIS CHAPTER 27 OSTEOPOROSIS AND OSTEOMALACIA DEFINITION OF OSTEOPOROSIS THE EPIDEMIOLOGY AND CONSEQUENCES OF OSTEOPOROSIS REVIEW OF BONE REMODELING BONE LOSS PATHOGENESIS OF OSTEOPOROSIS DIAGNOSIS OF OSTEOPOROSIS

More information

Nutrition for Family Living

Nutrition for Family Living Susan Nitzke, Nutrition Specialist; susan.nitzke@ces.uwex.edu Sherry Tanumihardjo, Nutrition Specialist; sherry.tan@ces.uwex.edu Amy Rettammel, Outreach Specialist; arettamm@facstaff.wisc.edu Betsy Kelley,

More information

Prevention of bone loss and vertebral fractures in patients with chronic epilepsy Antiepileptic drug and osteoporosis prevention trial

Prevention of bone loss and vertebral fractures in patients with chronic epilepsy Antiepileptic drug and osteoporosis prevention trial FULL-LENGTH ORIGINAL RESEARCH Prevention of bone loss and vertebral fractures in patients with chronic epilepsy Antiepileptic drug and osteoporosis prevention trial * #Antonio A. Lazzari, **Philip M. Dussault,

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF PRIMARY OSTEOPOROSIS

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF PRIMARY OSTEOPOROSIS European Medicines Agency London, 16 November 2006 Doc. Ref. CPMP/EWP/552/95 Rev. 2 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT

More information

Trans people and osteoporosis

Trans people and osteoporosis Trans Care Medical issues Trans people and osteoporosis What is Osteoporosis? Osteo means bone, and porosis means porous or sponge-like. Osteoporosis refers to bones becoming less dense and more spongy.

More information

D. Vitamin D. 1. Two main forms; vitamin D2 and D3

D. Vitamin D. 1. Two main forms; vitamin D2 and D3 D. Vitamin D. Two main forms; vitamin D2 and D3 H H D3 - Cholecalciferol D2 - Ergocalciferol Technically, vitamin D is not a vitamin. It is the name given to a group of fat-soluble prohormones (substances

More information

Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis. Disclosure and Conflicts of Interest Steven T Harris MD 2014-2015

Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis. Disclosure and Conflicts of Interest Steven T Harris MD 2014-2015 Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco steve.harris@ucsf.edu Disclosure

More information

Drug treatment pathway for Osteoporosis in Postmenopausal Women

Drug treatment pathway for Osteoporosis in Postmenopausal Women Drug treatment pathway for Osteoporosis in Postmenopausal Women Version 1.0 Ratified by: East Sussex HEMC Date ratified: 26.01.2011 Job title of originator/author Gillian Ells, East Sussex HEMC Pharmacist

More information

Calcium and Vitamin D Nutrition in the Elderly. Functions of Calcium. OCW: Geriatric Dentistry (E. Krall)

Calcium and Vitamin D Nutrition in the Elderly. Functions of Calcium. OCW: Geriatric Dentistry (E. Krall) 1. 2. Functions of Calcium Page - 1 3. Regulation of calcium: Hypocalcemia 4. Regulation of calcium: Hypercalcemia Page - 2 5. Calcium Homeostasis 6. Calcium absorption Page - 3 7. Some factors influencing

More information

EPILEPSY. & Men s Health

EPILEPSY. & Men s Health EPILEPSY & Men s Health HORMONAL EFFECTS in Men with Epilepsy Does epilepsy affect hormones? Yes, epilepsy is associated with hormonal changes. For instance, experts estimate that approximately 40 percent

More information

Anticonvulsant Drugs

Anticonvulsant Drugs North American AED Pregnancy Registry: Comparative Safety of Some Anticonvulsant Polytherapies LEWIS B. HOLMES, M.D., Director MassGeneral Hospital for Children Boston, MA E-mail: holmes.lewis@mgh.harvard.edu

More information

Fourth Year Medical Students Required Written Patient Care Assignments Reflecting Awareness of Use of Vitamin D in Older Patients at Risk for Falling

Fourth Year Medical Students Required Written Patient Care Assignments Reflecting Awareness of Use of Vitamin D in Older Patients at Risk for Falling Fourth Year Medical Students Required Written Patient Care Assignments Reflecting Awareness of Use of Vitamin D in Older Patients at Risk for Falling John Agens, M.D. Associate Professor in Geriatrics

More information

Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care

Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

More information

Outline Introduction Oidti Oxidative damage Antioxidants properties Antioxidants and antiaging interventions Hormonal therapy Benefits of DHEA, testos

Outline Introduction Oidti Oxidative damage Antioxidants properties Antioxidants and antiaging interventions Hormonal therapy Benefits of DHEA, testos Anti-Aging Aging g Medications What is the Evidence? Sixth Annual Family Medicine Conference Crown Plaza November 11, 2007 Presented by : Jad J. Sakr, Pharm.D. Outline Introduction Oidti Oxidative damage

More information

Bone Basics National Osteoporosis Foundation 2013

Bone Basics National Osteoporosis Foundation 2013 When you have osteoporosis, your bones become weak and are more likely to break (fracture). You can have osteoporosis without any symptoms. Because it can be prevented and treated, an early diagnosis is

More information

Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50 64

Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50 64 ORIGINAL RESEARCH Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50 64 Jennifer L. Pecina, MD, Lindy Romanovsky, MB, ChB, Stephen P. Merry, MD, Kurt A. Kennel, MD, and Tom

More information

BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW (BRONJ) BISPHOSPHONATES AND WHAT HAPPENS TO BONE VINCENT E. DIFABIO, DDS, MS MEMBER OF THE COMMITTEE ON HEALTHCARE AND ADVOCACY FROM THE AMERICAN ASSOCIATION

More information

PRACTICAL DENSITOMETRY

PRACTICAL DENSITOMETRY PRACTICAL DENSITOMETRY The Challenge of Osteoporosis Osteoporosis is a silent disease that develops over decades Goal: identify patients with osteoporosis before fractures occur Means: measure bone density

More information

Osteoporosis. Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist. Rheumatology and Arthritis Seminar Tuesday 5 th February 2013

Osteoporosis. Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist. Rheumatology and Arthritis Seminar Tuesday 5 th February 2013 Osteoporosis Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist Rheumatology and Arthritis Seminar Tuesday 5 th February 2013 Plan What is osteoporosis? Consequences of osteoporosis Risk factors

More information

PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES

PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES Patients newly diagnosed as osteopenic or osteoporotic on a radiology report or patients receiving abnormal lab values on the following lab tests

More information

OSTEOPOROSIS REHABILITATION PROGRAM

OSTEOPOROSIS REHABILITATION PROGRAM OSTEOPOROSIS REHABILITATION PROGRAM Tricia Orme, R.N. BSc(N) Mary Pack Arthritis Program Victoria i Arthritis i Centre Objectives Participants will gain an understanding of what Osteoporosis is and how

More information

A Treatment Algorithm for Indian Patients of Osteoporosis

A Treatment Algorithm for Indian Patients of Osteoporosis Indian Medical Gazette FEBRUARY 2012 67 Symposia Update A Treatment Algorithm for Indian Patients of Osteoporosis Shailendra Mohan Lakhotia, Senior Consultant Orthopedic Surgeon, Kolkata 700 045. Prashant

More information

16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS

16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS 16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS Goal Reduce the impact of several major musculoskeletal conditions by reducing the occurrence, impairment, functional limitations, and limitation

More information

Recent Topics in Treatment of Osteoporosis

Recent Topics in Treatment of Osteoporosis Review Article Recent Topics in Treatment of Osteoporosis JMAJ 49(9 10): 309 314, 2006 Satoshi Soen* 1 Abstract It has come to light that osteoporosis-related fractures are more critical than previously

More information

Osteoporosis. Overview

Osteoporosis. Overview Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)

More information

Treatment of osteoporosis in fragility fractures

Treatment of osteoporosis in fragility fractures Orthogeriatrics Clinical Summary Document Treatment of osteoporosis in fragility fractures Fragility fractures are extremely prevalent in older adults with a staggering cost of treatment. As the population

More information

Risk of seizure recurrence after antiepileptic drug withdrawal in Thai children with epilepsy

Risk of seizure recurrence after antiepileptic drug withdrawal in Thai children with epilepsy Neurology Asia 2006; 11 : 25 29 Risk of seizure recurrence after antiepileptic drug withdrawal in Thai children with epilepsy Pairoj BOONLUKSIRI MD Hatyai Hospital, Hatyai, Songkhla, Thailand Abstract

More information

Scans and tests and osteoporosis

Scans and tests and osteoporosis Scans and tests and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,

More information

Drug treatments to protect your bones

Drug treatments to protect your bones Drug treatments to protect your bones This information is an extract from the booklet, Bone health. You may find the full booklet helpful. We can send you a copy free see page 5. Contents Bisphosphonates

More information

Vitamin D. Sources of vitamin D

Vitamin D. Sources of vitamin D 1 has been in the news frequently this past year, including an article in The New York Times on November 16, 2009. So what is this vitamin? Why is it important? Most people have heard that vitamin D is

More information

José E. Cavazos, MD PhD San Antonio VA Epilepsy Center of Excellence (VISN 17) Audie L. Murphy VA Medical Center. (210)

José E. Cavazos, MD PhD San Antonio VA Epilepsy Center of Excellence (VISN 17) Audie L. Murphy VA Medical Center. (210) José E. Cavazos, MD PhD San Antonio VA Epilepsy Center of Excellence (VISN 17) Audie L. Murphy VA Medical Center (210) 617-5161 cavazosj@uthscsa.edu AEDs and Drug Interactions Objectives: Identify at least

More information

What You Need to Know for Better Bone Health

What You Need to Know for Better Bone Health What You Need to Know for Better Bone Health A quick lesson about bones: Why healthy bones matter The healthier your bones The more active you can be Bone health has a major effect on your quality of life

More information

Vitamin D, Parathyroid Hormone, and Bone Mineral Density Status in Kidney Transplant Recipients

Vitamin D, Parathyroid Hormone, and Bone Mineral Density Status in Kidney Transplant Recipients Transplantation Vitamin D, arathyroid Hormone, and Bone Mineral Density Status in Kidney Transplant Recipients Shokoufeh Savaj, Farinaz J Ghods Firoozgar Hospital, Tehran University of Medical Sciences,

More information

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal Code: Country: Phone Number:

More information

Osteoporosis. The inside looks like honeycomb, with blood vessels and bone marrow in the spaces between bone.

Osteoporosis. The inside looks like honeycomb, with blood vessels and bone marrow in the spaces between bone. Osteoporosis The bones in our skeleton are made of a thick outer shell and a strong inner mesh filled with collagen (protein), calcium salts and other minerals. Osteoporosis The inside looks like honeycomb,

More information

2-1. Osteoporose. Dr. P. Van Wettere Radiologie en medische beeldvorming

2-1. Osteoporose. Dr. P. Van Wettere Radiologie en medische beeldvorming 2-1 Osteoporose Dr. P. Van Wettere Radiologie en medische beeldvorming 2-2 Osteoporose Definitie Incidentie, mortaliteit, morbiditeit, kost Diagnose Radiologie Botdensitometrie FRAX FractureCascade History

More information

CONSENT FORM FOR THE CALCIUM/VITAMIN D PART OF THE WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL TRIAL

CONSENT FORM FOR THE CALCIUM/VITAMIN D PART OF THE WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL TRIAL WHI - Volume 1, Section 2 - Consent Form for the Calcium/Vitamin D Part of the WHI Clinical Trial Page 1 CONSENT FORM FOR THE CALCIUM/VITAMIN D PART OF THE WOMEN'S HEALTH INITIATIVE (WHI) CLINICAL TRIAL

More information

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 87 of 593

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 87 of 593 Measure #40 (NQF 0048): Osteoporosis: Management Following Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care 2015

More information

Recommendations for Care of the Osteoporotic Fracture Patient to. Reduce the Risk of Future Fracture

Recommendations for Care of the Osteoporotic Fracture Patient to. Reduce the Risk of Future Fracture Recommendations for Care of the Osteoporotic Fracture Patient to Reduce the Risk of Future Fracture Developed by the World Orthopedic Osteoporosis Organization (WOOO) Olof Johnell 1, John Kaufman 2, Steven

More information

Medications for Prevention and Treatment of Osteoporosis

Medications for Prevention and Treatment of Osteoporosis 1 Medications for Prevention and Treatment of Osteoporosis Osteoporosis is a disease where the strength of bones is less than normal, making them more susceptible to fracture, or breaking, than normal

More information

Epilepsy 101: Getting Started

Epilepsy 101: Getting Started American Epilepsy Society 1 Epilepsy 101 for nurses has been developed by the American Epilepsy Society to prepare professional nurses to understand the general issues, concerns and needs of people with

More information

11 BMD: Interpretation and Normal Ranges

11 BMD: Interpretation and Normal Ranges 11 BMD: Interpretation and Normal Ranges Introduction Bone mineral density measurements are frequently used in clinical practice to assess fracture risk. The utility of these measurements depends on making

More information

Clinical Policy Title: Medical alert devices and other interventions for vulnerable peoples safety at home

Clinical Policy Title: Medical alert devices and other interventions for vulnerable peoples safety at home Clinical Policy Title: Medical alert devices and other interventions for vulnerable peoples safety at home Clinical Policy Number: 17.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21,

More information

Use of a Peripheral Dexa Measurement for Osteoporosis Screening

Use of a Peripheral Dexa Measurement for Osteoporosis Screening Vol. 34, No. 3 201 Clinical Research and Methods Use of a Peripheral Dexa Measurement for Osteoporosis Screening Julienne K. Kirk, PharmD; Mindy Nichols, RD; John G. Spangler, MD Background and Objectives:

More information

Osteoporosis - recent advances in diagnosis and treatment. Creative Commons: Attribution 3.0 Hong Kong License

Osteoporosis - recent advances in diagnosis and treatment. Creative Commons: Attribution 3.0 Hong Kong License Title Osteoporosis - recent advances in diagnosis and treatment Author(s) Kung, AWC Citation The 4th Medical Research Conference, Hong Kong, China, 30-31 January 1999, v. 21 n. Supp, p. 3-10 Issued Date

More information

Bone Densitometry. What is a Bone Density Scan (DXA)?

Bone Densitometry. What is a Bone Density Scan (DXA)? Scan for mobile link. Bone Densitometry Bone densitometry, also called dual-energy x-ray absorptiometry or DEXA, uses a very small dose of ionizing radiation to produce pictures of the inside of the body

More information

Osteoporosis Background and Screening Recommendations. Maria K Jorgensen. Concordia University

Osteoporosis Background and Screening Recommendations. Maria K Jorgensen. Concordia University Osteoporosis Background and Screening Recommendations Maria K Jorgensen Concordia University Master of Public Health Applied Epidemiology December 15, 2014 Osteoporosis Background and Screening Recommendations

More information

Seizure recurrence after a first unprovoked seizure: With and without treatment. Mohammad Reza Najafi*, Ali Mehrabi**, Farideh Najafi***

Seizure recurrence after a first unprovoked seizure: With and without treatment. Mohammad Reza Najafi*, Ali Mehrabi**, Farideh Najafi*** Received: 3.4.2007 Accepted: 18.3.2008 Seizure recurrence after a first unprovoked seizure: With and without treatment Mohammad Reza Najafi*, Ali Mehrabi**, Farideh Najafi*** Abstract BACKGROUND: Most

More information

Considerations With Calcium And Vitamin D Supplementation

Considerations With Calcium And Vitamin D Supplementation Considerations With Calcium And Vitamin D Supplementation Activity Preview Calcium is an electrolyte involved in many systems in the body including bone health, nerve signaling pathways, muscle contractions,

More information

Osteoporosis and Arthritis: Two Common but Different Conditions

Osteoporosis and Arthritis: Two Common but Different Conditions and : Two Common but Different Conditions National Institutes of Health and Related Bone Diseases ~ National Resource Center 2 AMS Circle Bethesda, MD 20892 3676 Tel: 800 624 BONE or 202 223 0344 Fax:

More information

Osteoporosis Drugs In Asia Pacific Market Growth & Trends by 2022

Osteoporosis Drugs In Asia Pacific Market Growth & Trends by 2022 Osteoporosis Drugs In Asia Pacific Market Growth & Trends by 2022 Report Description Osteoporosis is a progressive, skeletal disease, leading to fragile and abnormally porous bones. It is characterized

More information

Facts About Aging and Bone Health

Facts About Aging and Bone Health Facts About Aging and Bone Health A Guide to Better Understanding and Well Being with the compliments of Division of Health Services Diocese of Camden Exercise as treatment Along with medication, proper

More information

Does chronic lymphocytic leukemia increase the risk of osteoporosis?

Does chronic lymphocytic leukemia increase the risk of osteoporosis? Does chronic lymphocytic leukemia increase the risk of osteoporosis? Amrita Desai, MD Internal Medicine Residency Program Adam Olszewski, MD Department of Hematology and Oncology Memorial Hospital of Rhode

More information

CPT 76977, 77078, 77079, 77080, 77081, 77083, or HCPCS G0130:

CPT 76977, 77078, 77079, 77080, 77081, 77083, or HCPCS G0130: Bone Mass Measurements Coverage Information Noridian Administrative Services (NAS), LLC, is providing coverage information regarding Bone Mass Measurements (BMM) in response to multiple provider inquiries.

More information

CMAJ JAMC. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada

CMAJ JAMC. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada CANADIAN M EDICAL A SSOCIATION J OURNAL J OURNAL DE L ASSOCIATION MÉDICALE CANADIENNE CMAJ JAMC 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada CMAJ 2002;167(10

More information

Medications to Prevent and Treat Osteoporosis

Medications to Prevent and Treat Osteoporosis Medications to Prevent and Treat Osteoporosis National Institutes of Health Osteoporosis and Related Bone Diseases ~ National Resource Center 2 AMS Circle Bethesda, MD 20892-3676 Tel: (800) 624-BONE or

More information

25-hydroxyvitamin D: from bone and mineral to general health marker

25-hydroxyvitamin D: from bone and mineral to general health marker DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate

More information

Clinical Policy Title: Medical alert devices and other interventions for vulnerable peoples safety at home

Clinical Policy Title: Medical alert devices and other interventions for vulnerable peoples safety at home Clinical Policy Title: Medical alert devices and other interventions for vulnerable peoples safety at home Clinical Policy Number: 17.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21,

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium pregabalin, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg and 300mg capsules. (Lyrica ) (No. 145/04) Pfizer 10 December 2004 The Scottish Medicines Consortium (SMC) has completed

More information

Vitamin D (serum, plasma)

Vitamin D (serum, plasma) Vitamin D (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Vitamin D 1.2 Alternative names The term vitamin D covers a group of closely related naturally occurring lipid soluble compounds

More information

Graves disease in childhood Antithyroid drug therapy

Graves disease in childhood Antithyroid drug therapy 83rd Annual Meeting of the ATA October 620, 203 Duration of antithyroid drugs treatment Disclosure Nothing to disclose Pr Juliane Léger Paediatric Endocrinology Department Paris Diderot University Hôpital

More information

1. What are anti-epileptic drugs? Anti-epileptic drugs (AEDs) are prescribed to control seizures. They do not cure epilepsy.

1. What are anti-epileptic drugs? Anti-epileptic drugs (AEDs) are prescribed to control seizures. They do not cure epilepsy. 14 FREQUENTLY ASKED QUESTIONS ON ANTI- EPILEPTIC DRUGS 1. What are anti-epileptic drugs? Anti-epileptic drugs (AEDs) are prescribed to control seizures. They do not cure epilepsy. 2. When should treatment

More information

Bone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring

Bone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring Bone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring Richard Eastell, MD FRCP FRCPath FMedSci, Professor of Bone Metabolism, University of Sheffield, Sheffield, UK Usefulness of

More information

GUIDE FOR VITAMIN D IN CHILDHOOD

GUIDE FOR VITAMIN D IN CHILDHOOD GUIDE FOR VITAMIN D IN CHILDHOOD October 2013 Introduction There are many different recommendations for the prevention, detection and treatment of Vitamin D deficiency in the UK. The following is a practical

More information

Hormonal Oral Contraceptives: An Overview By Kelsie Court. A variety of methods of contraception are currently available, giving men and

Hormonal Oral Contraceptives: An Overview By Kelsie Court. A variety of methods of contraception are currently available, giving men and Hormonal Oral Contraceptives: An Overview By Kelsie Court A variety of methods of contraception are currently available, giving men and women plenty of options in choosing a method suitable to his or her

More information

Press Information. Vitamin D deficiency

Press Information. Vitamin D deficiency DSM, Corporate Communications P.O. Box 6500, 6401 HJ Heerlen The Netherlands phone +31 (0) 45 578 2421 www.dsm.com Vitamin D is one of the essential nutrients for human health. Unlike other types of vitamins

More information

Pediatric Latent TB Diagnosis and Treatment

Pediatric Latent TB Diagnosis and Treatment Date Updated: April 2015 Guidelines Reviewed: 1. CDC Latent TB Guidelines 2. Harborview Pediatric Clinic Latent TB Management, 2010 3. Pediatric Associates Latent TB Guidelines, 2013 4. Seattle Children

More information

The menopausal transition usually has three parts:

The menopausal transition usually has three parts: The menopausal transition usually has three parts: Perimenopause begins several years before a woman s last menstrual period, when the ovaries gradually produce less estrogen. In the last 1-2 years of

More information

Osteoporosis. Drugs to prevent bone fractures in people with: Contents. 2: Our Recommendations. 3: Welcome. 6: Who Needs Drugs to Prevent Fractures?

Osteoporosis. Drugs to prevent bone fractures in people with: Contents. 2: Our Recommendations. 3: Welcome. 6: Who Needs Drugs to Prevent Fractures? Drugs to prevent bone fractures in people with: Osteoporosis Comparing Effectiveness, Safety, and Price Contents 2: Our Recommendations 3: Welcome 6: Who Needs Drugs to Prevent Fractures? 8: Choosing a

More information

Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients

Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients Age and Ageing 1999; 28: 265 269 Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients YOSHIHIRO SATO,HARUKO KUNO, TAKESHI ASOH, YOSHIAKI HONDA,

More information

Easy-to-Read Information for Patients and Families. U.S. Department of Health and Human Services National Institutes of Health

Easy-to-Read Information for Patients and Families. U.S. Department of Health and Human Services National Institutes of Health BONE HEALTH FOR LIFE Easy-to-Read Information for Patients and Families U.S. Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and

More information

Vitamin K 2 treatment for postmenopausal osteoporosis in Indonesia

Vitamin K 2 treatment for postmenopausal osteoporosis in Indonesia Blackwell Publishing AsiaMelbourne, AustraliaJOGThe Journal of Obstetrics and Gynaecology Research1341-87626 Asia and Oceania Federation of Obstetrics and Gynaecology2632223234Original ArticleVitamin K2

More information

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal

More information

The Fragility Fractured Bone

The Fragility Fractured Bone The Fragility Fractured Bone Is Connected To... FPO osteoporosis future fractures pain suffering disability Hope and Help 1 No Bones About It You ve seen your health care provider and the diagnosis is

More information

THE BURDEN OF OSTEOPOROSIS IN WEST VIRGINIA

THE BURDEN OF OSTEOPOROSIS IN WEST VIRGINIA THE BURDEN OF OSTEOPOROSIS IN WEST VIRGINIA Bob Wise Governor Paul L. Nusbaum, Secretary Department of Health and Human Resources Chris Curtis, M.P.H. Acting Commissioner, Bureau for Public Health Catherine

More information

Consumer and Family Sciences

Consumer and Family Sciences Purdue Extension Consumer and Family Sciences Department of Foods and Nutrition CFS-150-W Osteoporosis: What You Should Know April C. Mason, Ph.D. William D. Evers, Ph.D., RD Erin E. Hanley, RD Osteoporosis,

More information

Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women 1,2

Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women 1,2 Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women 1,2 Allan G Need, Michael Horowitz, Howard A Morris, and BE Christopher Nordin ABSTRACT Background:

More information

Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy

Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Today s speaker is Samir Taneja, MD Program moderator is Pam Barrett, Us TOO International Made possible

More information